Dopamine beta hydroxylase

This MedLibrary.org supplementary page on Dopamine beta hydroxylase is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Dopamine beta-hydroxylase (dopamine beta-monooxygenase)
Identifiers
Symbols DBH; DBM
External IDs OMIM: 609312 MGI94864 HomoloGene615
EC number 1.14.17.1
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 1621 13166
Ensembl ENSG00000123454 ENSMUSG00000000889
Uniprot P09172 Q3V1U4
Refseq NM_000787 (mRNA)
NP_000778 (protein)
NM_138942 (mRNA)
NP_620392 (protein)
Location Chr 9: 135.49 - 135.51 Mb Chr 2: 26.99 - 27 Mb
Pubmed search [1] [2]

Dopamine β-hydroxylase (DBH) is an enzyme that converts dopamine to norepinephrine: Synonyms: Aromatic L-amino acid decarboxylase (EC 4.1.1.28, tryptophan decarboxylase, 5-hydroxytryptophan decarboxylase, AAAD) is a lyase enzyme.

DBH is a 290 kDa copper-containing oxygenase consisting of four identical subunits, and its activity requires ascorbate as a cofactor. [1] It is the only enzyme involved in the synthesis of small-molecule neurotransmitters that is membrane-bound, making norepinephrine and epinephrine the only transmitters synthesized inside vesicles. It is expressed in noradrenergic nerve terminals of the central and peripheral nervous systems, as well as in chromaffin cells of the adrenal medulla.

DBH is inhibited by disulfiram, [2] tropolone, [3] and, most selectively, by nepicastat. [4]

See also

References

  1. ^ Rush RA, Geffen LB (1980). "Dopamine beta-hydroxylase in health and disease.". Crit Rev Clin Lab Sci. 12 (3): 241–77. doi:10.3109/10408368009108731. PMID 6998654. 
  2. ^ Goldstein M, Anagnoste B, Lauber E, McKeregham MR (1964). "Inhibition of dopamine-beta-hydroxylase by Disulfiram.". Life Sci 3: 763–7. doi:10.1016/0024-3205(64)90031-1. PMID 14203977. 
  3. ^ Goldstein M, Lauber E, McKeregham MR (1964). "Inhibition of dopamine-beta-hydroxylase by tropolone and other chelating agents.". Biochem Pharmacol 13: 1103–6. doi:10.1016/0006-2952(64)90109-1. PMID 14201135. 
  4. ^ Stanley WC et al. (1997). "Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase.". British Journal of Pharmacology 121 (8): 1803–9. doi:10.1038/sj.bjp.0701315. PMID 9283721. 

External links


Wikipedia content modification information:

  • This page was last modified on 8 October 2008, at 01:19.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Dopamine beta hydroxylase".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.